This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q66036882
rdf:type
wikibase:Item
schema:description
clinical trial ensayu clínicu клінічне випробування կլինիկական փորձարկում klinisch onderzoek
rdfs:label
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
skos:prefLabel
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
schema:name
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
p:P1476
wds:Q66036882-993FF7C3-328A-47E3-8553-DC30FF811821
wdt:P1476
A Randomized Phase II Study: Sequencing Topoisomerase Inhibitors for Extensive Stage Small Cell Lung Cancer (SCLC): Topotecan Sequenced With Etoposide/Cisplatin, and Irinotecan/Cisplatin Sequenced With Etoposide
p:P582
wds:Q66036882-BEA25B13-FE77-4446-873A-5AE54580A00B
wdt:P582
2012-01-01T00:00:00Z
p:P31
wds:Q66036882-017E91B4-D8DF-42EA-9015-DB744EAD016E
wdt:P31
wd:Q30612
p:P580
wds:Q66036882-8E7CE46C-9869-49DF-92E1-C2AEB927F5CC
wdt:P580
2004-03-01T00:00:00Z
p:P17
wds:Q66036882-7B9A3AC1-152C-4071-B387-EF7913ABFCE8
wdt:P17
wd:Q30
p:P6153
wds:Q66036882-917B3496-35F0-4E54-B637-4A3C1F963B89 wds:Q66036882-951CA7C8-FB0F-4FAB-85B8-FF448522CF44 wds:Q66036882-7FA4E6F0-1777-42C1-A01C-C74EB9238BA8 wds:Q66036882-40AFD97C-3C5E-48DC-85D4-22594EF9BA52 wds:Q66036882-F7640726-C516-46A7-8F99-64574ECDE49C wds:Q66036882-B627FD8C-5CD6-4332-B9E7-318A109309E5 wds:Q66036882-B7DA29A9-50C4-45B7-9B0A-A67DBF836E9A
wdt:P6153
wd:Q30289179 wd:Q87932226 wd:Q6806287 wd:Q4980899 wd:Q61676534 wd:Q1047060 wd:Q7896459
p:P4844
wds:Q66036882-7DAA5EEB-BD6D-4686-8259-1250DD349179 wds:Q66036882-14A90F99-94EE-4547-A9DA-2F9C1592B4C6 wds:Q66036882-204862D6-CCDE-47F0-B828-6B86C3290A48 wds:Q66036882-580E963E-75DE-4B33-9F50-E974FADCB065 wds:Q66036882-F9B68C81-6E5E-4F74-A56B-51FB4AB4B80F
wdt:P4844
wd:Q412415 wd:Q27260984 wd:Q412197 wd:Q421193 wd:Q3950557
p:P2899
wds:Q66036882-47957EB2-07AB-47F2-B627-E9FF51F56AA0
wdt:P2899
18
p:P1132
wds:Q66036882-DE60B7EF-1F40-41BB-816B-308AB84D5CAA
wdt:P1132
140
p:P8363
wds:Q66036882-6B436F62-BE61-402F-A993-9B35C1851802
wdt:P8363
wd:Q78089383
p:P3098
wds:Q66036882-20F439FA-2134-4120-91A8-D20D6BF4E71E
wdt:P3098
NCT00057837
p:P6099
wds:Q66036882-DA390205-3E7D-4173-8047-A8F99F80F21E
wdt:P6099
wd:Q42824440